Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.81NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.160.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.71ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.177.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.177.71NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.445ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.445ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.1.445ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.445NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.21 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.21 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.21 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.21 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
B.1.1.112ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.112NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.123ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.123ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.123ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.123NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.143ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.143ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.143ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.143NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.48ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.48NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.46.6.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.46.6.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.46.6.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.46.6.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.112.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.112.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.112.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used